The Patent Finder

A Method of Treating Diabetes Type 2 by Metformin and an Ultrarapid Acting Insulin

MannKind Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 61/087,943, filed Aug 11, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,119,593A Method of Treating Diabetes Type 2 by Metformin and an Ultrarapid Acting Insulin
In force
 · High confidence
MannKind CorporationIn force
High confidence
US 9,943,571Use of Ultrarapid Acting Insulin
In force
 · High confidence
MannKind CorporationIn force
High confidence
US 10,857,207Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin
In force
 · High confidence
MannKind CorporationIn force
High confidence
US 11,110,151Composition and Method for Reducing Hypoglycemia Events in Diabetes Treatment
In force
 · High confidence
MannKind CorporationIn force
High confidence
US 11,998,591Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin
In force
 · High confidence
MannKind CorporationIn force
High confidence
US 8,623,817A Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin
In force
 · High confidence
MannKind CorporationIn force
High confidence
US 11,980,656A Method of Treating Hypoglycemia Events in Diabetes Treatment
In force
 · Medium confidence
MannKind CorporationIn force
Medium confidence
Application 18/593,204Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin
Pending
Not granted
MannKind CorporationPendingNot granted
Application 18/612,971Method of Treating Hypoglycemia Events in Diabetes Treatment
Pending
Not granted
MannKind CorporationPendingNot granted
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by MannKind Corporation.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited